�Nephros Announces Inclusion in the Russell Microcap® Index

Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that the company has been added to the Russell Microcap ® Index at the conclusion of the 2026 annual reconstitution. Nephros’ inclusion in the index became effective after the US market closed on June 26, 2026. Membership in the Russell Microcap ® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

“We are pleased to be joining the Russell Microcap ® Index, which follows a year of significant achievement with exciting growth potential ahead. We believe our inclusion will not only help deliver long-term value to our shareholders will but increase our visibility with potential institutional and other new investors,” said Robert Banks, President and Chief Executive Officer .

About the Russell Indexes Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $10.6 trillion in assets are benchmarked against Russell’s US indexes. Russell indexes are part of FTSE Russell, a leading global index provider. For more information on the Russell Microcap ® Index and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website .

About Nephros Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products a...